AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2022
Feb 4, 2022
32044_dirs_2022-02-04_c690c2d2-3cb1-4cb1-8d1d-199bc175f4e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-02-02
Reporting Person: Perez Jeffrey Thomas (SVP, IP Affairs)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-02 | Option to Purchase Common Stock (Right to Buy) | $2.33 | A | 150000 | Acquired | 2032-02-02 | Common Stock (150000) | Direct |
Footnotes
F1: The option vests in four equal installments on each of February 2, 2023, February 2, 2024, February 2, 2025 and February 2, 2026.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23